About this course
Obstructive sleep apnea (OSA) and non-alcoholic fatty liver disease (NAFLD) / metabolic dysfunction associated fatty liver disease (MAFLD) are two conditions commonly affecting individuals with metabolic disorders, particularly obesity. Prompt recognition of these diseases is important to reduce morbidity among obese patients. This e-learning module provides a brief overview on the diagnosis and management of obstructive sleep apnea and provides a primary care approach to fatty liver disease.
Learning outcomes
Upon completion of the educational activity, participants should be able to:
- Understand OSA
- Identify clinical characteristics of OSA
- Review the diagnosis and initial management of OSA
- Review metabolic dysfunction associated fatty liver disease (MAFLD)
- Management of MAFLD
Topics covered
- OSA
- Overview
- When to suspect OSA in patients
- Initial things to do before referring to a specialist
- Diagnosis
- Treatment
- Fatty Liver
- Overview
- NAFLD and MAFLD
- Management of MAFLD
- Fatty liver in patients with type 2 diabetes mellitus
Keywords: obesity, obstructive sleep apnea, fatty liver
In collaboration with: